Patents Assigned to ASAT AG Applied Science & Technology
-
Patent number: 8062648Abstract: The present invention relates to a composition which comprises as active ingredients a combination of melatonin, ginkgo biloba and biotin. The composition is particularly suitable for producing formulations for topical application in the hair.Type: GrantFiled: October 30, 2003Date of Patent: November 22, 2011Assignee: ASAT AG Applied Science & TechnologyInventor: Hans W. Schmid
-
Patent number: 8017645Abstract: The present invention relates to a disposable container for a medicament or cosmetic agent for topical application, containing a single dose of melatonin or of a melatonin derivative which corresponds to a locally effective dose but which does not cause any systemic effect.Type: GrantFiled: May 7, 2008Date of Patent: September 13, 2011Assignee: ASAT AG Applied Science & TechnologyInventor: Hans W. Schmid
-
Publication number: 20080293803Abstract: The present invention relates to a disposable container for a medicament or cosmetic agent for topical application, containing a single dose of melatonin or of a melatonin derivative which corresponds to a locally effective dose but which does not cause any systemic effect.Type: ApplicationFiled: May 7, 2008Publication date: November 27, 2008Applicant: ASAT AG APPLIED SCIENCE & TECHNOLOGYInventor: Hans W. SCHMID
-
Publication number: 20060099278Abstract: The present invention relates to a composition which comprises as active ingredients a combination of melatonin, ginkgo biloba and biotin. The composition is particularly suitable for producing formulations for topical application in the hair.Type: ApplicationFiled: October 30, 2003Publication date: May 11, 2006Applicant: ASAT AG APPLIED SCIENCE & TECHNOLOGYInventor: Hans Schmid
-
Publication number: 20060035924Abstract: The present invention relates to a disposable container for a medicament or cosmetic agent for topical application, containing a single dose of melatonin or of a melatonin derivative which corresponds to a locally effective dose but which does not cause any systemic effect.Type: ApplicationFiled: October 30, 2003Publication date: February 16, 2006Applicant: ASAT AG Applied Science & TechnologyInventor: Hans Schmid
-
Publication number: 20040202659Abstract: The invention relates to novel nucleic acid sequences which encode human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins, to novel amino acid sequences of human antibodies, and to their use for the diagnosis and therapy of diseases.Type: ApplicationFiled: May 13, 2004Publication date: October 14, 2004Applicant: ASAT AG APPLIED SCIENCE & TECHNOLOGYInventors: Peter Berchtold, Robert F. A. Escher
-
Patent number: 6790938Abstract: The invention relates to novel nucleic acid sequences which encode human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins, to novel amino acid sequences of human antibodies, and to their use for the diagnosis and therapy of diseases.Type: GrantFiled: December 3, 1999Date of Patent: September 14, 2004Assignee: ASAT AG Applied Science & TechnologyInventors: Peter Berchtold, Robert F. A. Escher
-
Publication number: 20040043390Abstract: Nucleotide sequences are used to store meaningful information, such as letters, words, phrases, signs, icons, musical notes, numbers or bits and bitmaps in any cultural context including languages, phonetics, multimedia applications, codes, abbreviations, personal and scientific information. The information is stored by creating a plurality of codons composed of nucleotides that it is readable by any technique that is capable of analyzing nucleotide sequences. The information can also be encrypted by all known or to be developed algorithms of cryptography.Type: ApplicationFiled: September 20, 2002Publication date: March 4, 2004Applicant: ASAT AG Applied Science & TechnologyInventor: Beda M. Stadler
-
Patent number: 6559183Abstract: The present invention relates to a composition comprising a nano-emulsion that contains 5-aminolevulinic acid as well as a carrier in an aqueous phase. This invention also relates to a pharmaceutical preparation containing this composition. The nano-emulsions of this type can be used in photodynamic therapy as well as in the photodiagnostic detection of proliferatives cells.Type: GrantFiled: July 26, 2001Date of Patent: May 6, 2003Assignee: ASAT AG Applied Science & TechnologyInventors: Hans W. Schmid, Gerd Burmeister
-
Patent number: 6281241Abstract: The invention relates to the use of melatonin and melatonin-containing preparations for the treatment of androgenetic alopecia of the female type.Type: GrantFiled: February 18, 2000Date of Patent: August 28, 2001Assignee: ASAT AG Applied Science and TechnologyInventor: Peter Elsner